Microfluidic Device with Hydrophobic Confinement for 3D Tissue Compression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro and in vivo models for drug testing are inefficient and costly, with traditional two-dimensional cell cultures and animal models failing to accurately predict drug behavior in humans due to limitations in mechanical stimulation and species differences, leading to unreliable and ethically contentious testing methods.
Innovation Solution
A microfluidic device with a culture chamber featuring hydrophobic, pervious confinement means and a mobile counter element for controlled compression of cellular matrices, allowing for the generation and maturation of three-dimensional cell and tissue constructs that mimic native tissue mechanics, using polymers like fibrin and collagen to create a matrix that can be compressed cyclically to enhance tissue differentiation and maturation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional two-dimensional cell cultures on flat rigid substrates are used, then the model is simple to maintain, but the predictive accuracy of drug behavior in vivo is poor
Solution Approach 1:
The patent transitions from traditional two-dimensional cell cultures to three-dimensional tissue constructs. The confinement means create a three-dimensional space where cells can self-organize and form tissue-like structures, thereby improving predictive accuracy by better replicating the native three-dimensional architecture of human tissues.
Solution Approach 2:
The patent introduces dynamic mechanical compression through the mobile counter element that can be moved between resting and compression positions. This dynamic mechanical stimulation mimics physiological conditions and enhances tissue maturation, improving the reliability of drug behavior prediction without requiring overly complex static structures.
2Reliability
If animal models are used for pre-clinical testing, then in vivo interaction can be studied, but species differences reduce reliability for human drug testing
Solution Approach 1:
The patent creates in vitro copies of human tissue structures using human cells cultured in three-dimensional confinement. These engineered tissue constructs replicate the mechanical and structural properties of native human tissues, providing a reliable human-relevant model without requiring animal subjects or large quantities of rare human cells.
Solution Approach 2:
The patent changes the physical parameters of the culture system by implementing controlled mechanical compression and three-dimensional confinement. These parameter changes enable human cells to differentiate and mature into tissue-like structures that accurately reflect human physiology, thereby improving reliability for human drug testing.
3Reliability
If three-dimensional tissue constructs are generated, then native tissue mechanics are better replicated, but the device complexity increases
Solution Approach 1:
The patent divides the culture system into distinct functional components: confinement means for three-dimensional structuring, mobile counter element for mechanical compression, and culture medium reservoirs. This segmentation allows each component to perform its specific function efficiently, achieving complex three-dimensional tissue cultivation without requiring an overly complex integrated system.
Solution Approach 2:
The confinement means serve multiple functions: they provide three-dimensional structural confinement, enable culture medium perfusion through their pervious nature, and facilitate mechanical compression. This multi-functionality reduces the number of separate components needed, thereby managing device complexity while achieving reliable native tissue mechanics replication.
4Manufacturing precision
If cyclic mechanical compression is applied to enhance tissue maturation, then differentiation accuracy improves, but the operational complexity increases
Solution Approach 1:
The patent implements periodic cyclic mechanical compression by moving the counter element between resting and compression positions. This periodic action mimics physiological mechanical stimuli and enhances tissue differentiation and maturation control, achieving high manufacturing precision while maintaining operational simplicity through repetitive motion.
Solution Approach 2:
The mobile counter element provides dynamic mechanical stimulation that can be adjusted between static and cyclic compression modes. This dynamic capability allows precise control over tissue differentiation while maintaining ease of operation through a single movable component that can be actuated in different patterns.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device enables the efficient and economical generation of mature three-dimensional tissue constructs that better replicate human tissue behavior, reducing the need for animal testing and improving drug screening accuracy through controlled mechanical stimulation and perfusion, allowing for rapid and reliable differentiation and maturation of cells.
Implementation Method 1
said confinement means being hydrophobic and pervious to the culture medium
Implementation Method 2
said confinement means being hydrophobic and pervious to the culture medium
Implementation Method 3
the confinement means and the at least one counter element are reciprocally mobile between a resting position and a compression position of the cellular matrix
Implementation Method 4
using polymers like fibrin and collagen to create a matrix that can be compressed cyclically
Data Source
AI summary
A microfluidic device for controlled generation and/or culture and/or maturation of three-dimensional cells and/or tissue constructs that includes a culture chamber may include: a confinement apparatus configured to define at least one compartment configured to contain a cellular matrix and at least one compartment configured to contain a culture medium, the confinement apparatus being hydrophobic and pervious to the culture medium; and/or at least one counter element. The confinement apparatus and at least one counter element may be reciprocally mobile between resting and compression positions of the cellular matrix. A method for controlled generation and/or culture and/or maturation of three-dimensional cells and/or tissue constructs at a microscale may include: controlled compression of a cellular matrix for a predetermined period of time. The cellular matrix may be delimited by a confinement apparatus that is pervious to a culture medium.